Recent Finacing
Recent Raise
HDAX Therapeutics develops HDAC6-targeting small-molecule therapeutics using a novel molecular recognition mechanism to improve binding, pharmacokinetics, and selectivity, advancing discovery and preclinical programs for neurological and cardiometabolic indications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors